Dr. Choi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2121 Kenny Rd
6TH FL
Columbus, OH 43210Phone+1 614-293-3196Fax+1 614-293-4812
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2015 - 2018
- Albert Einstein College of MedicineClass of 2015
Certifications & Licensure
- MA State Medical License 2021 - 2026
- OH State Medical License 2024 - 2026
- NY State Medical License 2018 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 10 citationsCheckpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.Sanjal H Desai, Michael A Spinner, Kevin David, Veronika Bachanova, Gaurav Goyal
American Journal of Hematology. 2023-03-01 - Expanding landscape for relapsed Hodgkin lymphomaYun Choi, Catherine Diefenbach
Blood. 2021-08-12 - 1 citationsImmunotherapy with drugsYun Choi, Catherine Diefenbach
Hematology. American Society of Hematology. Education Program. 2020-12-04
Abstracts/Posters
- The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)Yun Kyong Choi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...Yun Kyong Choi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- Non-Chemo Regimen Highly Active in R/R Hodgkin LymphomaAugust 23rd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: